Balancing risk and benefit during coronavirus.
作者信息
Sehn Laurie H
机构信息
Associate Editor, Blood.
出版信息
Blood. 2020 May 21;135(21):1817. doi: 10.1182/blood.2020006279.
Abstract
摘要
相似文献
1
Balancing risk and benefit during coronavirus.在新冠疫情期间权衡风险与收益。
Blood. 2020 May 21;135(21):1817. doi: 10.1182/blood.2020006279.
2
Strategic plan for management of COVID-19 in paediatric haematology and oncology departments.儿科血液学和肿瘤学部门新冠病毒病管理战略计划
Lancet Haematol. 2020 May;7(5):e359-e362. doi: 10.1016/S2352-3026(20)30104-6. Epub 2020 Apr 1.
3
Managing patients with hematological malignancies during COVID-19 pandemic.在新冠疫情期间管理血液系统恶性肿瘤患者
Expert Rev Hematol. 2020 Aug;13(8):787-793. doi: 10.1080/17474086.2020.1787147. Epub 2020 Jul 12.
4
Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.血液系统恶性肿瘤中的冠状病毒：突破2019冠状病毒病中血管紧张素转换酶2（ACE2）屏障的靶向分子
Pathol Oncol Res. 2020 Oct;26(4):2823-2825. doi: 10.1007/s12253-020-00810-6. Epub 2020 Apr 24.
5
Radiotherapy & Oncology during the COVID-19 pandemic.新冠疫情期间的放射治疗与肿瘤学
Radiother Oncol. 2020 May;146:221-222. doi: 10.1016/j.radonc.2020.04.043. Epub 2020 Apr 28.
6
Impact of immunosuppression on mortality in critically ill COVID-19 patients.免疫抑制对危重症COVID-19患者死亡率的影响。
Br J Haematol. 2020 Nov;191(3):394-395. doi: 10.1111/bjh.17108. Epub 2020 Oct 26.
7
[Practical guidelines for the radiotherapy for patients presented with haematological malignancies in the epidemic COVID-19 situation: International Lymphoma Radiation Oncology Group recommendations].[新型冠状病毒肺炎疫情期间血液系统恶性肿瘤患者放射治疗实用指南：国际淋巴瘤放射肿瘤学组建议]
Cancer Radiother. 2020 Jun;24(3):194-195. doi: 10.1016/j.canrad.2020.04.005. Epub 2020 May 4.
8
COVID-19: how will this impact children with cancer, now and in the future?新冠病毒肺炎：这将如何影响现在及未来的癌症患儿？
Expert Rev Anticancer Ther. 2020 Jul;20(7):527-529. doi: 10.1080/14737140.2020.1781621. Epub 2020 Jun 30.
9
Oncology in the Time of COVID-19.新冠疫情时代的肿瘤学
Oncology (Williston Park). 2020 Apr 10;34(4):693720.
10
Novel coronavirus(Covid19), Its renal manifestations, and complications.新型冠状病毒（新冠病毒19）、其肾脏表现及并发症。
Urol J. 2020 Sep 13;17(5):558-559. doi: 10.22037/uj.v16i7.6431.
引用本文的文献
1
Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic.加拿大在冠状病毒大流行期间对慢性淋巴细胞白血病的管理。
Curr Oncol. 2020 Jun;27(3):e332-e335. doi: 10.3747/co.27.6769. Epub 2020 Jun 1.
2
Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19.柚皮苷，一种具有抗病毒和抗炎作用的类黄酮：一种有前途的对抗 COVID-19 的治疗策略。
Phytother Res. 2020 Dec;34(12):3137-3147. doi: 10.1002/ptr.6781. Epub 2020 Jul 2.
Zotero 插件